U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987968) titled 'A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy' on May 07.
Brief Summary: A Phase 2, Randomized, Controlled, Open-Label, Adaptive Dose Design, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Two Different Dwell Times of VS-01 on Top of Standard of Care versus Standard of Care Alone in Patients with Overt Hepatic Encephalopathy
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Hepatic Encephalopathy
Acute on Chronic Liver Failure (ACLF)
Decompensated Cirrhosis
Intervention:
DRUG...